Flagship Pioneering

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

Business Model:

Revenue: $10M

Employees: 201-500

Rankings

Detailed Flagship Pioneering Information

Geographic Data

Flagship Pioneering headquarters map

Address: 55 Cambridge Pkwy Ste 800E

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$6B

Metrics

667,932Website Global Rank

62,065Website Monthly Traffic

Twitter Followers

Description

Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. They accelerate Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology. Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies. They attract, develop, and retain the top scientific, entrepreneurial, and managerial talent in the world.

Contact Phone:
+16178681888

Contact Email:

Announced Date Company Transaction Money Raised
1/2001 AnVil Informatics, Inc Series A -
6/2010 Acceleron Pharma Venture Round 10.3M
12/2005 Resolvyx Pharmaceuticals Series A 17M
1/1999 Integrated Development Enterprise Seed Round -
7/2005 Ellacoya Networks Series D 13.5M
5/2005 Codon Devices Series A 13M
2/2007 BlackDuck Series C 12M
7/2004 BlackDuck Series A 5M
1/2012 Tarveda Therapeutics Series A 2.8M
7/2008 Accuri Cytometers Series C 13M
9/2007 Kovio Series D 19.5M
6/2003 Nanostream Inc. Series C 22M
5/2008 Mascoma Series C 61M
12/2013 Tarveda Therapeutics Series B 21M
3/2021 Omega Therapeutics Series C 126M
6/2011 Kovio Venture Round 0
11/2011 Agios Series C 78M
7/2004 ZoomInfo Series A 7M
11/2012 Quanterix Series C 0
9/2006 Alvine Pharmaceuticals Series A 21.5M
10/2006 Morphotek Series D 0
6/2009 Polatis Venture Round 8M
1/2021 Tessera Therapeutics Series B 0
8/2022 Senda Biosciences Series C 123M
2/2012 Helicos BioSciences Series A 27M
1/2004 CGI Pharmaceuticals Series C 22.3M
3/2013 T2 Biosystems Series E 40M
6/2006 Adnexus Series B 27M
8/2010 Visterra Debt Financing 6M
10/2014 Visterra Series B 30M
8/2005 Pervasis Therapeutics Series B 12.4M
9/2012 WikiCell Designs Series A 10M
10/2006 SiCortex Series B 21M
3/2013 Receptos Series B 30M
8/2006 Acceleron Pharma Series B 30M
10/2014 Selecta Biosciences Private Equity Round 20M
12/2005 Hypnion Series B 0
6/2010 BIND Therapeutics Series C 12.4M
2/2009 Selecta Biosciences Series B 15.1M
10/2014 Syros Pharmaceuticals Series B 53M
3/2013 Janssen Global Services Venture Round 13.5M
4/2011 Janssen Global Services Series B 18.4M
8/2014 YourBio Health Series B 16M
11/2012 Visterra Series A 26.1M
6/2016 Visterra Series C 23.1M
3/2003 Adnexus Series A 13M
8/2009 Pervasis Therapeutics Series C 17.4M
4/2004 Continuum Photonics Series C 17.5M
9/2004 SiCortex Series A 21M
2/2004 Morphotek Series C 26M
1/2005 Revivio Series C 25M
4/2008 Concert Pharmaceuticals Series C 0
12/2010 LS9 Series D 30M
12/2006 Codon Devices Series B 20M
8/2015 Editas Medicine Series B 0
10/2007 Acceleron Pharma Series C 31M
10/2003 AVEO Oncology Series B 42.7M
4/2022 Tessera Therapeutics Series C 0
2/2017 Tarveda Therapeutics Series D 30M
3/2010 TransMedics Series E 0
6/2010 Tetraphase Pharmaceuticals Series C 0
1/2019 Sana Biotechnology Seed Round -
10/2010 Accuri Cytometers Series E 6M
8/2009 Accuri Cytometers Series D 4M
8/2007 Adnexus Series C 15.5M
7/2009 Kovio Series E 20M
9/2014 BlackDuck Series F 0
6/2003 Trusted Network Technologies Series A 6M
8/2004 Affinnova Series C 4.5M
6/2020 Sana Biotechnology Series A 700M
10/2019 Cygnal Therapeutics Venture Round 65M
2/2012 Polatis Venture Round 0
8/2016 Denali Therapeutics Series B 130M
12/2022 Montai Health Series A 50M
5/2015 Axcella Series C 39M
2/2021 Cellarity Series B 0
12/2004 Pervasis Therapeutics Series A 2M
3/2013 Avedro Series D 0
8/2017 Omega Therapeutics Series A 28.4M
1/2020 Invaio Sciences Venture Round -
1/2012 Joule Unlimited, Inc. Series C 70M
8/2005 Extraprise Venture Round 0
12/2017 Janssen Global Services Series B 25M
1/2008 Pervasis Therapeutics Venture Round 9.8M
2/2007 Everyday Solutions Series A 6.8M
7/2007 Ze-gen Series A 5.5M
3/2022 Vesalius Therapeutics Venture Round 75M
5/2022 ProFound Therapeutics Private Equity Round 75M
1/2009 Celexion Venture Round -
11/2013 Moderna Therapeutics Venture Round 110M
11/2012 TransMedics Venture Round 36M
7/2016 Indigo Series C 100M
9/2018 Indigo Series E 250M
5/2009 Visterra Seed Round 3.3M
9/2017 Indigo Series D 203M
1/2020 Ohana Biosciences Venture Round -
11/2013 Editas Medicine Series A 43M
3/2004 Pervasis Therapeutics Seed Round 500k
11/2021 Alltrna Venture Round 50M
1/2020 Ring Therapeutics Venture Round 50M
11/2006 Concert Pharmaceuticals Series B 48.5M
3/2003 Hypnion Series B 47.5M
6/2003 Ellacoya Networks Venture Round 14M
8/2009 Advanced Electron Beams Series C 0
10/2015 Janssen Global Services Venture Round 32M
2/2005 Seahorse Bioscience Series C 11.5M
3/2009 Seahorse Bioscience Series D 6M
11/2013 EcoSense Lighting Venture Round 15M
1/2004 Genomics Collaborative Venture Round -
9/2005 Carbon Design Systems Series C 5.3M
7/2019 Valo Health Series A 100M
5/2015 Denali Therapeutics Series A 217M
1/2003 VIEO Series B 15M
2/2009 BlackDuck Series D 5M
12/2014 Seres Therapeutics Series C 48M
10/2002 Tira Wireless Series A 3M
7/2007 Tira Wireless Series D 5M
3/2020 Sigilon Series B 80.3M
2/2016 Indigo Series B 48.5M
1/2007 Ensemble Therapeutics Venture Round -
6/2018 Kaleido Series C 101M
6/2006 Zingku Venture Round 1M
5/2012 Sesen Bio, Inc. Series A 20M
5/2015 Joule Unlimited, Inc. Private Equity Round 40M
1/2004 Carbon Design Systems Series B 10M
10/2007 BDNA Series D 0
11/2015 Evelo Biosciences Series A 35M
1/2006 Interactive Supercomputing Series A 4.5M
6/2012 YourBio Health Series A 10M
10/2005 Affinity Express Venture Round 3M
4/2009 Avedro Series B 10M
3/2017 Oasys Water Series B 4M
2/2007 BIND Therapeutics Series A 2.5M
2/2002 BG Medicine Venture Round 11M
9/2006 Carbon Design Systems Series D 5M
11/2014 Indigo Series A 7.5M
6/2011 MedidaMetrics Venture Round 8.5M
9/2003 Selventa Series A 0
10/2009 LS9 Series C 25M
11/2015 Codiak Biosciences Series A 31M
1/2003 Blue Agave Software Series A 7M
1/2006 T2 Biosystems Series A 5.5M
1/2018 Inzen Therapeutics Venture Round -
5/2010 T2 Biosystems Series C 0
12/2019 Cellarity Funding Round 50M
10/2022 Cellarity Series C 121M
11/2016 YourBio Health Series C 10M
9/2021 YourBio Health Venture Round 21M
3/2006 Helicos BioSciences Series B 40M
7/2016 TransMedics Private Equity Round 0
8/2002 Flamenco Networks Series B 7.4M
12/2013 Visterra Series A 8.1M
10/2022 Inari Series E 0
4/2007 TransMedics Series D 0
8/2005 Intio Series A 829k
12/2002 Integrated Development Enterprise Venture Round 13.3M
3/2017 CIBO Technologies Venture Round 30.3M
9/2017 Kaleido BioSciences Series B 65M
9/2018 KSQ Therapeutics Series C 80M
11/2006 Mascoma Series B 30M
7/2008 Agios Series A 33M
11/2007 BIND Therapeutics Series B 16M
5/2021 Inari Series D 0
10/2017 KSQ Therapeutics Series B 76M
9/2020 Generate Biomedicines Venture Round 50M
5/2021 Invaio Sciences Series C 88.9M
3/2004 CombinatoRx Series C 30M
3/2015 Red Rock Biofuels Venture Round -
2/2009 Oasys Water Series A 10M
11/2009 Receptos Series A 25M
3/2002 Affinnova Series A 4M
2/2015 EcoSense Lighting Series C 25M
7/2008 BG Medicine Series D 40M
6/2005 BlackDuck Series B 12M
8/2021 Laronde Series B 440M
7/2021 Ring Therapeutics Series B 117M
1/2021 Valo Health Series B 190M
5/2005 Netuitive Series C 5M
7/2006 Mascoma Series A 4M
8/2020 Indigo Series F 360M
4/2021 Repertoire Immune Medicines Series B 0
1/2017 Incredible Foods Venture Round -
8/2002 NuVox Private Equity Round 78.5M
10/2013 Axcella Series A 10.8M
11/2018 Axcella Series E 0
5/2021 Laronde Series A 50M
7/2022 Apriori Bio Series A 0
12/2015 Rubius Therapeutics Series A 25M
6/2012 Tangent Medical Technologies Venture Round 7.9M
8/2019 Inari Series C 89M
1/2004 TransMedics Series B 27.6M
5/2008 Intio Convertible Note 1M
6/2010 Everyday Solutions Venture Round 2.8M
1/2006 Epitome Biosystems Venture Round -
12/2003 Blue Agave Software Series B 6M
1/2004 EngeneOS Venture Round -
7/2003 Affinnova Series B 6M
6/2009 Janssen Global Services Series A 15M
9/2003 IntelliVid Series A 5.5M
3/2018 Foghorn Therapeutics Venture Round 50M
5/2016 TransMedics Series F 0
10/2008 T2 Biosystems Series B 0
3/2005 Tira Wireless Series B 2.5M
12/2011 Permeon Biologics Venture Round 2.5M
6/2017 Rubius Therapeutics Series B 120M
3/2018 Rubius Therapeutics Series C 100M
4/2008 VisEn Medical Series B 0
10/2020 Senda Biosciences Series A 88M
3/2005 Tira Wireless Debt Financing 2.5M
10/2000 Hypnion Series A 10.4M
3/2017 Boragen Series A 10M
5/2004 Ensemble Discovery Series A 15M
4/2013 Syros Pharmaceuticals Series A 30M
3/2012 Receptos Venture Round 30M
11/2021 Generate Biomedicines Series B 0
11/2007 Ensemble Discovery Series B 15M
5/2008 Selecta Biosciences Seed Round 2.5M
8/2008 Quanterix Series A 15M
5/2008 Jinko Solar Series A -
8/2009 Novomer Series B 14M
10/2011 BlackDuck Series E 12M
11/2007 Novomer Series A 6.6M
12/2012 Moderna Therapeutics Venture Round 40M
7/2017 Evelo Biosciences Series B 50M
3/2006 TransMedics Series C 0
10/2017 Visterra Series C 0
4/2007 Netuitive Series D 8M
11/2017 Codiak Biosciences Series C 76.5M
4/2010 Selecta Biosciences Series C 15M
3/2007 LS9 Series A 5M
12/2013 Axcella Series B -
10/2005 Integrated Development Enterprise Venture Round 1.5M
5/2014 Seres Therapeutics Series B 10M
11/2013 Seres Therapeutics Series A 10.5M
11/2006 Tetraphase Pharmaceuticals Series A 10M
3/2004 Zalicus Series D 29.5M
3/2006 Tira Wireless Series C 13M
8/2008 Tetraphase Pharmaceuticals Series A 0
1/2008 Carbon Design Systems Series E 6M
8/2011 T2 Biosystems Series D 0
10/2021 CIBO Technologies Series C 0
9/2009 Tetraphase Pharmaceuticals Series B 0
5/2009 Carbon Design Systems Series E 7.5M
11/2012 Tangent Medical Technologies Series B 8.6M
10/2007 Interactive Supercomputing Series B 11M
1/2002 Renovis Series B 0
7/2020 Omega Therapeutics Series B 85M
1/2016 Codiak Biosciences Series B 61M
1/2015 Tarveda Therapeutics Series B 21M
5/2011 YourBio Health Series A 4.5M
1/2006 Calpurnia Corporation Series B 8M
3/2010 Sesen Bio, Inc. Series A 35M
1/2002 CombinatoRx Series B 40M
10/2007 LS9 Series B 15M
7/2002 Continuum Photonics Series B 14M
9/2006 Intio Series B 2M
11/2017 Repertoire Immune Medicines Series A 25M
6/2005 Brainshark Series C 0
4/2010 Joule Unlimited, Inc. Series B 30M
9/2009 Helicos BioSciences Post-IPO Equity 10M
9/2004 Ellacoya Networks Venture Round 7M
7/2022 Apriori Bio Series A 0
5/2022 ProFound Therapeutics Series A 0
4/2022 Tessera Therapeutics Series C 0
3/2022 Vesalius Therapeutics Series A 0
11/2021 Generate Biomedicines Series B 0
11/2021 Alltrna Venture Round 0
10/2021 CIBO Technologies Series C 0
9/2021 YourBio Health Venture Round 0
8/2021 Laronde Series B 0
7/2021 Ring Therapeutics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.